To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
Key claim: HR4541 reauthorizes CDC’s National Breast and Cervical Cancer Early Detection Program through FY2030 and young women’s breast-health awareness programs through FY2031, increases state grant spending flexibility, and requires a GAO report on individuals served and screening barriers.
Abstract
(HR4541 · 119th Congress) This bill reauthorizes and revises programs of the Centers for Disease Control and Prevention (CDC) that support services and education addressing breast and cervical cancer. The bill reauthorizes through FY2030 and makes changes to the CDC’s National Breast and Cervical Cancer Early Detection Program. This program provides grants to states for breast and cervical cancer screening, diagnostic, and treatment services for individuals who have low incomes, are uninsured, or otherwise lack access to such services. The bill increases flexibility in how states may spend grant funds under the program. The Government Accountability Office must report to Congress on the work of the National Breast and Cervical Cancer Early Detection Program, including the number of individuals served and barriers to accessing screenings. Also, the bill reauthorizes through FY2031 CDC programs relating to young women’s awareness of breast health and breast cancer. These programs include campaigns to educate young women and health care professionals, research on preventing breast cancer in younger women, and grants for resources and services to young women diagnosed with breast cancer and precancerous conditions. Latest action (2026-07-27): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Why this matters
HR4541 keeps two long-standing CDC programs — subsidized breast and cervical cancer screening for low-income, uninsured women and targeted breast-health outreach to women under 45 — from lapsing, extending them through FY2030 and FY2031 respectively. Added state grant flexibility could shift how NBCCEDP dollars are spent between screening, diagnostic services, and outreach, and the required GAO report may surface gaps in who is being reached. For patients, providers, and state health departments, the practical effect is continuity of no-cost screening access and awareness campaigns rather than a change in what is covered.